USPSTF Recommendations For Colon Cancer Screening At Age 45 Could Give Cologuard A Boost

05 Nov 2020

If the USPSTF recommendations are finalized, most insurers would need to reimburse Exact Sciences’ US FDA-approved at-home stool DNA test for colorectal cancer and encourage doctors to prescribe more at-home testing.

Colorectal cancer; medical anatomical illustration

A new US task force recommendation to lower the age of routine colorectal cancer screening to those aged 45 instead of 50 could encourage more physicians to offer earlier screening for their patients and at-home testing for colorectal cancer.

The proposal, put forth by the US Preventative Services Task Force (USPSTF) on 27 October, reflects the sharp increase in...